Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Oct 1;44(10):988-994.
doi: 10.1097/INF.0000000000004878. Epub 2025 May 28.

Maternal Immunization With RSVpreF Vaccine: Effectiveness in Preventing Respiratory Syncytial Virus-associated Hospitalizations in Infants Under 6 Months in Argentina: Multicenter Case-control Study

Angela Gentile  1 , María Del Valle Juárez  1 , María Florencia Lucion  1 , Gabriela Gregorio  2 , Oscar López  3 , Tatiana Fernández  2 , Andrés Gioiosa  2 , Silvina Lobertti  4 , Natalia Pejito  1 , Leandro López  3 , Gabriela Ensinck  4
Affiliations
Observational Study

Maternal Immunization With RSVpreF Vaccine: Effectiveness in Preventing Respiratory Syncytial Virus-associated Hospitalizations in Infants Under 6 Months in Argentina: Multicenter Case-control Study

Angela Gentile et al. Pediatr Infect Dis J. .

Abstract

Background: Respiratory syncytial virus (RSV) is a leading cause of morbidity and mortality in infants, particularly in those under 6 months. Starting March 2024, Argentina implemented the bivalent RSVpreF vaccine for pregnant women between 32.0 and 36.6 weeks of gestation during the RSV season. This report study aimed to assess the effectiveness of maternal immunization in preventing RSV-associated hospitalizations in infants under 6 months born to vaccinated and not vaccinated women, including their clinical and epidemiological characteristics.

Methods: A multicenter, prospective, observational, nested case-control study using a test-negative design was conducted. Data were collected through active epidemiological surveillance of respiratory infections in children under 18 years of age hospitalized at 4 pediatric referral hospitals in Argentina.

Results: Between January and October 2024, 1340 children were hospitalized for respiratory infections, including 187 infants born after March 15: 91 RSV-positive cases and 96 RSV-negative controls. RSV cases peaked in epidemiological week 26 (June). Compared to controls, RSV cases were younger ( P < 0.001) and had lower frequencies of comorbidities ( P < 0.001), prematurity ( P = 0.016) and chronic respiratory diseases ( P < 0.001). RSV maternal immunization was less frequent among RSV cases than controls (17.6% vs. 44.8%; P < 0.001). Vaccinated RSV cases had shorter duration of oxygen therapy (4 vs. 7 days; P < 0.001) and hospital stay (5 vs. 8 days; P < 0.001). The crude effectiveness of RSV immunization in infants under 6 months was 68.2% (95% confidence interval: 33.1%-84.9%) and 78.7% (95% confidence interval: 51.4%-90.7%) after adjustment for age under 3 months, prematurity and chronic respiratory disease.

Conclusion: In its first season, Argentina's maternal RSVpreF immunization demonstrated substantial effectiveness in reducing RSV-associated hospitalizations in infants and decreasing RSV disease severity.

Keywords: effectiveness; hospitalization; infants; maternal immunization; respiratory syncytial virus.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

References

    1. Shi T, McAllister DA, O’Brien KL, et al.; RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390:946–958.
    1. Scheltema NM, Gentile A, Lucion F, et al.; PERCH Study Group. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. Lancet Glob Health. 2017;5:e984–e991.
    1. Li Y, Wang X, Blau DM, et al.; Respiratory Virus Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399:2047–2064.
    1. Argentina Ministry of Health. Statistics and Health Information Direction. Vital Statistics. Basic Information. Argentina - Year 2022. Series 5 Number 66. Buenos Aires. 2024. Available from: https://www.argentina.gob.ar/sites/default/files/serie_5_nro_66_anuario_... . Accessed July 4, 2024.
    1. Gentile A, Lucion MF, Juárez MDV, et al. Burden of respiratory syncytial virus disease and mortality risk factors in Argentina: 18 years of active surveillance in a children’s hospital. Pediatr Infect Dis J. 2019;38:589–594.

Publication types

MeSH terms

Substances

LinkOut - more resources